{"id":"https://openalex.org/W3170103401","doi":"https://doi.org/10.1016/j.ejmech.2021.113562","title":"Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo","display_name":"Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo","publication_year":2021,"publication_date":"2021-05-30","ids":{"openalex":"https://openalex.org/W3170103401","doi":"https://doi.org/10.1016/j.ejmech.2021.113562","mag":"3170103401","pmid":"https://pubmed.ncbi.nlm.nih.gov/34116325"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejmech.2021.113562","doi":"https://doi.org/10.1016/j.ejmech.2021.113562","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2021.113562","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0223523421004116/pdf","source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0223523421004116/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038733212","display_name":"Alexey Koval","orcid":"https://orcid.org/0000-0002-8920-4426","observed_orcids":["https://orcid.org/0000-0002-8920-4426"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alexey Koval","raw_affiliation_strings":["Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059538213","display_name":"Ivan Bassanini","orcid":"https://orcid.org/0000-0001-9589-3689","observed_orcids":["https://orcid.org/0000-0001-9589-3689"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4403928382","display_name":"Istituto di Scienze e Tecnologie Chimiche \"Giulio Natta\"","ror":"https://ror.org/04r43k021","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210155236","https://openalex.org/I4403928382"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ivan Bassanini","raw_affiliation_strings":["Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy; Istituto di Scienze e Tecnologie Chimiche \"Giulio Natta\", Consiglio Nazonale delle Ricerche, 20131, Milano, Italy","Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy","Istituto di Scienze e Tecnologie Chimiche \"Giulio Natta\", Consiglio Nazonale delle Ricerche, 20131, Milano, Italy"],"raw_orcid":"https://orcid.org/0000-0001-9589-3689","affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy; Istituto di Scienze e Tecnologie Chimiche \"Giulio Natta\", Consiglio Nazonale delle Ricerche, 20131, Milano, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4403928382"]},{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"Istituto di Scienze e Tecnologie Chimiche \"Giulio Natta\", Consiglio Nazonale delle Ricerche, 20131, Milano, Italy","institution_ids":["https://openalex.org/I4403928382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101796300","display_name":"Jiabin Xu","orcid":"https://orcid.org/0000-0001-6024-3555","observed_orcids":["https://orcid.org/0000-0001-6024-3555"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jiabin Xu","raw_affiliation_strings":["Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland; Department of Biomedical Sciences, Faculty of Biology and Medicine, 1011, University of Lausanne, Lausanne, Switzerland","Department of Biomedical Sciences, Faculty of Biology and Medicine, 1011, University of Lausanne, Lausanne, Switzerland","Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland; Department of Biomedical Sciences, Faculty of Biology and Medicine, 1011, University of Lausanne, Lausanne, Switzerland","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"]},{"raw_affiliation_string":"Department of Biomedical Sciences, Faculty of Biology and Medicine, 1011, University of Lausanne, Lausanne, Switzerland","institution_ids":["https://openalex.org/I97565354"]},{"raw_affiliation_string":"Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009205030","display_name":"Michele Tonelli","orcid":"https://orcid.org/0000-0003-1518-2890","observed_orcids":["https://orcid.org/0000-0003-1518-2890"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Tonelli","raw_affiliation_strings":["Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084730796","display_name":"Vito Boido","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vito Boido","raw_affiliation_strings":["Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046656427","display_name":"Fabio Sparatore","orcid":"https://orcid.org/0000-0002-1657-9024","observed_orcids":["https://orcid.org/0000-0002-1657-9024"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabio Sparatore","raw_affiliation_strings":["Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy"],"raw_orcid":"https://orcid.org/0000-0002-1657-9024","affiliations":[{"raw_affiliation_string":"Dipartimento di Farmacia, Universit\u00e0 di Genova, 16132, Genova, Italy","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023783658","display_name":"Fr\u00e9d\u00e9ric C. Amant","orcid":"https://orcid.org/0000-0002-5452-4905","observed_orcids":["https://orcid.org/0000-0002-5452-4905","https://orcid.org/0000-0003-0180-0942"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210138709","display_name":"Centrum voor Gynaecologische Oncologie Amsterdam","ror":"https://ror.org/03sxzz606","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210138709"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","NL"],"is_corresponding":false,"raw_author_name":"Frederic Amant","raw_affiliation_strings":["Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven and Department of Oncology, 3000, Leuven, Belgium; Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek-Netherlands Cancer Institute (AvL-NKI), University Medical Center (UMC), 1066, Amsterdam, the Netherlands","Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek-Netherlands Cancer Institute (AvL-NKI), University Medical Center (UMC), 1066, Amsterdam, the Netherlands","Department of Obstetrics and Gynecology, University Hospitals Leuven and Department of Oncology, 3000, Leuven, Belgium","Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-5452-4905","affiliations":[{"raw_affiliation_string":"Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven and Department of Oncology, 3000, Leuven, Belgium; Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek-Netherlands Cancer Institute (AvL-NKI), University Medical Center (UMC), 1066, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210138709","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek-Netherlands Cancer Institute (AvL-NKI), University Medical Center (UMC), 1066, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210138709"]},{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University Hospitals Leuven and Department of Oncology, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046502523","display_name":"Daniela Annibali","orcid":"https://orcid.org/0000-0001-8413-7669","observed_orcids":["https://orcid.org/0000-0001-8413-7669"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Daniela Annibali","raw_affiliation_strings":["Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031459327","display_name":"Eleonora Leucci","orcid":"https://orcid.org/0000-0002-2898-748X","observed_orcids":["https://orcid.org/0000-0002-2898-748X"]},"institutions":[{"id":"https://openalex.org/I4210092815","display_name":"VIB-KU Leuven Center for Cancer Biology","ror":"https://ror.org/00eyng893","country_code":"BE","type":"facility","lineage":["https://openalex.org/I2802017950","https://openalex.org/I4210092815","https://openalex.org/I99464096"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eleonora Leucci","raw_affiliation_strings":["Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, 3000, Leuven, Belgium; Trace, LKI Leuven Cancer Institute, KU Leuven, 3000, Leuven, Belgium","Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, 3000, Leuven, Belgium","Trace, LKI Leuven Cancer Institute, KU Leuven, 3000, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-2898-748X","affiliations":[{"raw_affiliation_string":"Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, 3000, Leuven, Belgium; Trace, LKI Leuven Cancer Institute, KU Leuven, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I4210092815","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Trace, LKI Leuven Cancer Institute, KU Leuven, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059309705","display_name":"Anna Sparatore","orcid":"https://orcid.org/0000-0003-2135-2649","observed_orcids":["https://orcid.org/0000-0003-2135-2649"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Anna Sparatore","raw_affiliation_strings":["Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy. Electronic address: anna.sparatore@unimi.it","Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy. Electronic address: anna.sparatore@unimi.it","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, 20133, Milano, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087206207","display_name":"Vladimir L. Katanaev","orcid":"https://orcid.org/0000-0002-7909-5617","observed_orcids":["https://orcid.org/0000-0002-7909-5617"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I204947315","display_name":"Far Eastern Federal University","ror":"https://ror.org/0412y9z21","country_code":"RU","type":"education","lineage":["https://openalex.org/I204947315"]}],"countries":["CH","RU"],"is_corresponding":true,"raw_author_name":"Vladimir L. Katanaev","raw_affiliation_strings":["Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland; School of Biomedicine, Far Eastern Federal University, 690922, Vladivostok, Russia. Electronic address: vladimir.katanaev@unige.ch","Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland","School of Biomedicine, Far Eastern Federal University, 690922, Vladivostok, Russia"],"raw_orcid":"https://orcid.org/0000-0002-7909-5617","affiliations":[{"raw_affiliation_string":"Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland; School of Biomedicine, Far Eastern Federal University, 690922, Vladivostok, Russia. Electronic address: vladimir.katanaev@unige.ch","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I204947315"]},{"raw_affiliation_string":"Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, 1206, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229"]},{"raw_affiliation_string":"School of Biomedicine, Far Eastern Federal University, 690922, Vladivostok, Russia","institution_ids":["https://openalex.org/I204947315"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5059309705","https://openalex.org/A5087206207"],"corresponding_institution_ids":["https://openalex.org/I114457229","https://openalex.org/I189158943","https://openalex.org/I204947315"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":{"value":4150,"currency":"USD","value_usd":4150},"fwci":1.4716,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.82627992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"222","issue":null,"first_page":"113562","last_page":"113562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.04089999943971634,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clofazimine","display_name":"clofazimine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8930000066757202},{"id":"https://openalex.org/keywords/wnt-signaling-inhibition","display_name":"Wnt signaling inhibition","score":0.9459999799728394},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.718999981880188},{"id":"https://openalex.org/keywords/water-solubility","display_name":"water solubility","score":0.7250000238418579},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6710000038146973},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.593999981880188},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2776297342","wikidata":"https://www.wikidata.org/wiki/Q418611","display_name":"Clofazimine","level":3,"score":0.9345800280570984},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.8376169204711914},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7234594821929932},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6166964173316956},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5691605806350708},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5202837586402893},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4557192027568817},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2188422977924347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18051356077194214},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.17683145403862},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17517578601837158},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1425553858280182},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2780695269","wikidata":"https://www.wikidata.org/wiki/Q36956","display_name":"Leprosy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002991","descriptor_name":"Clofazimine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002991","descriptor_name":"Clofazimine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060449","descriptor_name":"Wnt Signaling Pathway","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":11,"locations":[{"id":"doi:10.1016/j.ejmech.2021.113562","doi":"https://doi.org/10.1016/j.ejmech.2021.113562","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2021.113562","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0223523421004116/pdf","source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:34116325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34116325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/54f48551-1bdd-4c95-93f8-354c465434dc","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/54f48551-1bdd-4c95-93f8-354c465434dc","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Koval, A, Bassanini, I, Xu, J, Tonelli, M, Boido, V, Sparatore, F, Amant, F, Annibali, D, Leucci, E, Sparatore, A & Katanaev, V L 2021, 'Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo', European journal of medicinal chemistry, vol. 222, 113562. https://doi.org/10.1016/j.ejmech.2021.113562","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:serval.unil.ch:BIB_8FFD711F824D","doi":null,"is_oa":true,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_8FFD711F824D","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry, vol. 222, pp. 113562","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:unige.ch:unige:152351","doi":null,"is_oa":true,"landing_page_url":"https://archive-ouverte.unige.ch/unige:152351","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 0223-5234","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:air.unimi.it:2434/851156","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2434/851156","pdf_url":"http://hdl.handle.net/2434/851156","source":{"id":"https://openalex.org/S4306400516","display_name":"Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I189158943","host_organization_name":"University of Milan","host_organization_lineage":["https://openalex.org/I189158943"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unil.ch:iris/158928","doi":null,"is_oa":true,"landing_page_url":"https://iris.unil.ch/handle/iris/158928","pdf_url":"https://iris.unil.ch/bitstreams/8e83b787-6b16-4d0e-b8ea-1f1c1d3e64b2/download","source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/684882","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/684882","pdf_url":"https://lirias.kuleuven.be/retrieve/e9e07706-665b-4d86-a272-b51513ce01c2","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal Of Medicinal Chemistry, vol. 222, Art.No. ARTN 113562","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/714f018b-0ab1-45e4-a0ee-40f009600f61","doi":null,"is_oa":true,"landing_page_url":"https://pure.amc.nl/en/publications/optimization-of-the-clofazimine-structure-leads-to-a-highly-watersoluble-c3aminopyridinyl-riminophenazine-endowed-with-improved-antiwnt-and-anticancer-activity-in-vitro-and-in-vivo(714f018b-0ab1-45e4-a0ee-40f009600f61).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European journal of medicinal chemistry, 222:113562. Elsevier Masson SAS","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unige.it:11567/1049613","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11567/1049613","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:unige.ch:aou:unige:152351","doi":null,"is_oa":true,"landing_page_url":"https://archive-ouverte.unige.ch/unige:152351","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0223-5234","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.ejmech.2021.113562","doi":"https://doi.org/10.1016/j.ejmech.2021.113562","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2021.113562","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0223523421004116/pdf","source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6608132051","display_name":null,"funder_award_id":"17C153","funder_id":"https://openalex.org/F4320322884","funder_display_name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung"}],"funders":[{"id":"https://openalex.org/F4320310389","display_name":"Novartis Foundation","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320322884","display_name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320323831","display_name":"Universit\u00e9 de Lausanne","ror":"https://ror.org/019whta54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3170103401.pdf","grobid_xml":"https://content.openalex.org/works/W3170103401.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W202380478","https://openalex.org/W1968217711","https://openalex.org/W1973545565","https://openalex.org/W1973927012","https://openalex.org/W1987423991","https://openalex.org/W1995092510","https://openalex.org/W1998880511","https://openalex.org/W2008956402","https://openalex.org/W2018918964","https://openalex.org/W2025135899","https://openalex.org/W2034033569","https://openalex.org/W2040263952","https://openalex.org/W2069365343","https://openalex.org/W2081322171","https://openalex.org/W2093490960","https://openalex.org/W2125159822","https://openalex.org/W2136183527","https://openalex.org/W2147278996","https://openalex.org/W2217812638","https://openalex.org/W2474659529","https://openalex.org/W2582772886","https://openalex.org/W2620820557","https://openalex.org/W2754205305","https://openalex.org/W2800632780","https://openalex.org/W2805309434","https://openalex.org/W2896002881","https://openalex.org/W2911905836","https://openalex.org/W2912186110","https://openalex.org/W2913008433","https://openalex.org/W2956229469","https://openalex.org/W2978092928","https://openalex.org/W2982321934","https://openalex.org/W2982465000","https://openalex.org/W3111295927"],"related_works":["https://openalex.org/W1979939406","https://openalex.org/W2911905836","https://openalex.org/W2588419607","https://openalex.org/W7135226374","https://openalex.org/W7001697304","https://openalex.org/W4392956922","https://openalex.org/W4307704059","https://openalex.org/W3169986265","https://openalex.org/W2530707215","https://openalex.org/W1546256568"],"abstract_inverted_index":{"Triple-negative":[0],"breast":[1],"cancer":[2,6],"(TNBC)":[3],"is":[4,20],"a":[5,44,69,105,123],"subtype":[7],"critically":[8],"dependent":[9],"upon":[10],"excessive":[11],"activation":[12],"of":[13,24,119,127,133],"Wnt":[14,26,70,110],"pathway.":[15],"The":[16],"anti-mycobacterial":[17],"drug":[18],"clofazimine":[19,43,59],"an":[21],"efficient":[22],"inhibitor":[23],"canonical":[25],"signaling":[27,111],"in":[28,34,37,112,116,122],"TNBC,":[29],"reducing":[30],"tumor":[31,120],"cell":[32],"proliferation":[33],"vitro":[35],"and":[36,66,95],"animal":[38],"models.":[39],"These":[40],"properties":[41],"make":[42],"candidate":[45],"to":[46,61,99],"become":[47],"first":[48],"targeted":[49,91],"therapy":[50,92],"against":[51,93,109],"TNBC.":[52,128],"In":[53],"this":[54],"work,":[55],"we":[56],"optimized":[57],"the":[58,77,84,89,101,131],"structure":[60],"enhance":[62],"its":[63],"water":[64],"solubility":[65],"potency":[67,108],"as":[68,83],"inhibitor.":[71],"After":[72],"extensive":[73],"structure-activity":[74],"relationships":[75],"investigations,":[76],"riminophenazine":[78],"5-(4-(chlorophenyl)-3-((2-(piperazin-1-yl)ethyl)imino)-N-(pyridin-3-yl)-3,5-dihydrophenazin-2-amine":[79],"(MU17)":[80],"was":[81],"identified":[82],"new":[85],"lead":[86],"compound":[87],"for":[88],"riminophenazine-based":[90],"TNBC":[94,113],"Wnt-dependent":[96],"cancers.":[97],"Compared":[98],"clofazimine,":[100],"water-soluble":[102],"MU17":[103,138],"displayed":[104,139],"7-fold":[106],"improved":[107],"cells":[114],"resulting":[115],"on-target":[117],"suppression":[118],"growth":[121],"patient-derived":[124],"mouse":[125],"model":[126],"Moreover,":[129],"allowing":[130],"administration":[132],"reduced":[134],"yet":[135],"effective":[136],"dosages,":[137],"no":[140,145],"adverse":[141],"effects,":[142],"most":[143],"notably":[144],"clofazimine-related":[146],"skin":[147],"coloration.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-06-22T00:00:00"}